![[刘小婷]](https://staticres.ablesci.com/avatar/u/b901337a524b2f8aa312b155bd115e5c.png?v=5b0f)
Lv61
2820 积分 2022-09-21 加入
Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats
4天前
已完结
Physiological and Pathological Roles of NTSR2 in Several Organs and Diseases (Review)
4天前
已完结
The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance
4天前
已完结
Spinal NTS2 receptor activation reverses signs of neuropathic pain
4天前
已完结
Abstract CT010: Phase I dose-escalation and expansion study of JS107, a claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC), as monotherapy or in combination for patients (pts) with advanced solid tumors
5天前
已关闭
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
5天前
已完结
Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog
17天前
已完结
The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain
18天前
已完结
The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain
18天前
已完结
Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain
20天前
已完结
皖公网安备34019202002308
